Physician Profile
Christopher L. Littlejohn, M.D. practices hematology & oncology in Longview, TX. Christopher is a 2016 graduate of Texas A & M University System, Hsc, College of Medicine. Christopher is also listed as specializing in internal medicine and student in an organized health care education program. According to Medicare claims data, Christopher cared for 1,749 Medicare patients across 117,956 services. The services billed most often include injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use), injection, azacitidine, 1 mg, and injection, darbepoetin alfa, 1 microgram (non-esrd use).
Summarised automatically from public NPI registry and CMS Medicare data. Not written or reviewed by this provider. Claim this profile to replace it.
Source: NPPES NPI Registry
1300 N 4TH ST
Longview, TX 75601
Within Hematology and Oncology generally. Availability varies by clinician, training and location — this profile has not been claimed, so nothing here is a personal claim by the provider.
Most searched conditions
Advanced Cancers
Blood & Lymph Disorders
Blood Cancers
Blood Disorders
Blood disorders
Bone & Soft Tissue Cancers
Digestive Cancers
Endocrine Cancers
Endocrine tumors
Gastrointestinal cancer
General oncology
Genetic Blood Disorders
Gynecologic cancer
Gynecologic Cancers
Head & Neck Cancers
Head and neck cancer
Neurologic Cancers
Oncologic emergencies
Ophthalmologic oncology
Skin cancer
Skin Cancers
Urologic Cancers
Most searched procedures
Biopsies & Diagnostics
Blood disorder care
Cancer Therapies
Cancer therapy
Cellular Therapies
Consultations
Diagnostic testing
Hematology Treatments
Imaging
Infusions
Interventional oncology
Supportive Cancer Care
Supportive cancer care
Surgical & Vascular Access
Testing & Genetics
Vascular access care
117,956 services · 1,749 patients · 25 distinct codes
| Procedure | Type | Code | Services |
|---|---|---|---|
| Insertion of needle into vein for collection of blood sample | Procedure | 36415 |
656 |
| Administration of chemotherapy into vein, 1 hour or less | Treatment | 96413 |
334 |
| Injection of additional new drug or substance into vein | Treatment | 96375 |
275 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Treatment | 96401 |
229 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Treatment | 96367 |
211 |
| Injection, azacitidine, 1 mg | Drug given | J9025 |
14,800 |
| Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Drug given | J0881 |
14,460 |
| Injection, pembrolizumab, 1 mg | Drug given | J9271 |
14,000 |
| Injection, paclitaxel, 1 mg | Drug given | J9267 |
8,338 |
| Injection, iron sucrose, 1 mg | Drug given | J1756 |
8,300 |
Source: CMS Medicare public data. Shows how often procedures were billed — not quality of care or patient satisfaction.
Christopher L. Littlejohn is a cancer specialist in Longview, TX. That is the designation recorded for this NPI in the federal registry, where it is listed as “Hematology & Oncology”.
NPI registry
Christopher L. Littlejohn is listed at 1300 N 4Th St, Longview, TX 75601. Addresses come from the NPI registry and can lag a move, so confirm before travelling.
NPI registry
The number on file is (903) 757-2122. Guide.md cannot book appointments or pass on messages — please call the office directly.
NPI registry
Christopher L. Littlejohn's National Provider Identifier is 1952764318. It is issued by the Centers for Medicare & Medicaid Services and is unique and permanent — it does not change if they move practice.
NPI registry
Christopher L. Littlejohn attended Texas A & M University System, Hsc, College of Medicine, graduating in 2016. This comes from the CMS National Downloadable File.
CMS public data
Christopher L. Littlejohn has 10 years experience. Calculated from a graduation year of 2016, reported in the CMS National Downloadable File.
CMS public data
According to Medicare billing data, Christopher L. Littlejohn performs procedures including insertion of needle into vein for collection of blood sample; provides treatments such as administration of chemotherapy into vein, 1 hour or less and injection of additional new drug or substance into vein, alongside routine visits and testing. This reflects Medicare patients only and is billing volume, not a measure of quality.
Medicare claims
Not yet. This profile is built from public federal data and has not been confirmed by Christopher L. Littlejohn. If this is you, claiming it is free.
Guide.md
Provider data sourced from the NPPES NPI Registry and CMS public datasets. Information is provided for reference and is not medical advice.